These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 8627041
1. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children. Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ, Starr SE. J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041 [Abstract] [Full Text] [Related]
2. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children. Vesikari T, Ohrling A, Baer M, Delem A, Bogaerts H, André FE. Acta Paediatr Scand; 1991 Nov; 80(11):1051-7. PubMed ID: 1661057 [Abstract] [Full Text] [Related]
8. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. White CJ, Stinson D, Staehle B, Cho I, Matthews H, Ngai A, Keller P, Eiden J, Kuter B. Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794 [Abstract] [Full Text] [Related]
10. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine. Just M, Berger R, Just V. Dev Biol Stand; 1986 May; 65():85-8. PubMed ID: 3030863 [Abstract] [Full Text] [Related]
12. Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine. Berger R, Just M. J Biol Stand; 1988 Oct; 16(4):275-9. PubMed ID: 2848843 [Abstract] [Full Text] [Related]
13. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy. Durando P, Esposito S, Bona G, Cuccia M, Desole MG, Ferrera G, Gabutti G, Pellegrino A, Salvini F, Henry O, Povey M, Marchetti F. Vaccine; 2016 Aug 05; 34(36):4278-84. PubMed ID: 27423382 [Abstract] [Full Text] [Related]
14. Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX. Shinefield HR, Black SB, Staehle BO, Adelman T, Ensor K, Ngai A, White CJ, Bird SR, Matthews H, Kuter BJ. Pediatr Infect Dis J; 1998 Nov 05; 17(11):980-5. PubMed ID: 9849978 [Abstract] [Full Text] [Related]
15. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Pauksen K, Duraj V, Ljungman P, Sjölin J, Oberg G, Lönnerholm G, Fridell E, Smedmyr B, Simonsson B. Bone Marrow Transplant; 1992 Jun 05; 9(6):427-32. PubMed ID: 1628126 [Abstract] [Full Text] [Related]
19. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. King GE, Markowitz LE, Heath J, Redd SC, Coleman S, Bellini WJ, Sievert A. JAMA; 1996 Mar 06; 275(9):704-7. PubMed ID: 8594268 [Abstract] [Full Text] [Related]
20. Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children. Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P. Pediatr Infect Dis J; 2006 Jan 06; 25(1):12-8. PubMed ID: 16395096 [Abstract] [Full Text] [Related] Page: [Next] [New Search]